comparemela.com

Page 13 - Winship Cancer Institute Of Emory University News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dr Dhodapkar on the Role of Linvoseltamab in Relapsed/Refractory Multiple Myeloma

Madhav V. Dhodapkar, MBBS, discusses the advantages and disadvantages of bispecific antibodies and CAR T-cell therapy in patients with relapsed/refractory multiple myeloma, as well as the potential role for the bispecific antibody linvoseltamab in this treatment paradigm.

Spotting breast cancer early: An Emory employee s story

In recognition of Breast Cancer Awareness Month in October, Emory employee Antonia Gillespie shares her story about how early detection was key to discovering cancer in its early stages.

Dr Hunter on the Ongoing Investigation into JAK Inhibitors in Myelofibrosis

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.